Nanding, Abdulrahman .

HRN: 15-57-71  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/07/2023
09/13/2023
IV
4.5g
Q6
Scrotal Abscess
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Skin & Soft TissueMultiple Infections (tick All Sites)    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: